Covered recipient · General Payments record
STEPHANI R SHOAF
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2021–2024
$5,981.15
- Reported across 260 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,172.20 | 50 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $262.06 | 10 |
| Lexicon Pharmaceuticals, Inc. | $113.19 | 1 |
| Incyte Corporation | $97.93 | 5 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $95.52 | 2 |
| Merck Sharp & Dohme Corporation | $80.36 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $67.41 | 3 |
| Regeneron Healthcare Solutions, Inc. | $54.59 | 2 |
| EISAI INC. | $51.03 | 3 |
| Deciphera Pharmaceuticals Inc. | $35.05 | 2 |
| Acerta Pharma LLC | $31.76 | 2 |
| EMD Serono, Inc. | $26.65 | 1 |
| Alexion Pharmaceuticals, Inc. | $24.89 | 1 |
| Janssen Biotech, Inc. | $21.73 | 1 |
| Amgen Inc. | $20.38 | 1 |
| Novo Nordisk AS | $20.02 | 1 |
| Kiniksa Pharmaceuticals International, plc | $18.81 | 1 |
| PFIZER INC. | $17.40 | 1 |
| Esperion Therapeutics, Inc. | $17.00 | 1 |
| Karyopharm Therapeutics Inc. | $16.87 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.62 | 1 |
| Pharmacosmos Therapeutics Inc. | $14.82 | 1 |
| Genmab U.S., Inc. | $14.64 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $13.98 | 1 |
| Apellis Pharmaceuticals, Inc. | $13.58 | 1 |
| Janssen Pharmaceuticals, Inc | $13.53 | 1 |
| SERVIER PHARMACEUTICALS LLC | $13.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (50)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.